|
|
|
Volumn 12, Issue 12, 2009, Pages 750-753
|
|
Ubiquitin drug discovery and diagnostics 2009 - First annual conference
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BORTEZOMIB;
BRCA1 PROTEIN;
CARFILZOMIB;
CEP 18770;
HBX 41108;
LENALIDOMIDE;
MLN 4924;
MLN 9708;
P 00509;
P 005091;
PANOBINOSTAT;
PERIFOSINE;
PROTEASOME INHIBITOR;
PROTEIN BAP1;
SALINOSPORAMIDE A;
TANESPIMYCIN;
UBIQUITIN;
UBIQUITIN PROTEIN LIGASE;
UNCLASSIFIED DRUG;
VORINOSTAT;
WNT PROTEIN;
CANCER RESEARCH;
CONFERENCE PAPER;
DRUG MECHANISM;
DRUG RESEARCH;
DRUG STRUCTURE;
DRUG TARGETING;
HUMAN;
MULTIPLE MYELOMA;
PERIPHERAL NEUROPATHY;
TREATMENT INDICATION;
UNITED STATES;
ANIMALS;
ANTINEOPLASTIC AGENTS;
DRUG DELIVERY SYSTEMS;
DRUG DESIGN;
DRUG DISCOVERY;
DRUGS, INVESTIGATIONAL;
HUMANS;
MULTIPLE MYELOMA;
NEOPLASMS;
PROTEASOME ENDOPEPTIDASE COMPLEX;
UBIQUITIN;
|
|
EID: 71249108218
PISSN: 13697056
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (3)
|
|
References (0)
|
